Arbutus Biopharma Corp (ABUS) — Capital Reinvestment Ratio

Latest as of March 2022: 0.00x

Arbutus Biopharma Corp (ABUS) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($20.62 Million) in capital expenditures ($75.00K). See net asset quality index of Arbutus Biopharma Corp to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$20.62 Million
USD

Capital Expenditures

$75.00K
USD

Data as of

Mar 2022
Most recent filing

Arbutus Biopharma Corp Capital Reinvestment Ratio (2012–2012)

This chart tracks Arbutus Biopharma Corp's Capital Reinvestment Ratio across 1 annual periods. Check ABUS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Arbutus Biopharma Corp (2012–2012)

Year-by-year Capital Reinvestment Ratio for Arbutus Biopharma Corp from 2012 to 2012. For live market cap and broader valuation context, see ABUS company net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2012 0.00x $33.27 Million $14.90K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow